Timothy Walbert, Horizon Pharma chairman & CEO. The Dublin based pharma group has  raised its offer to buy Depomed to $33 per share, contingent on the smaller drugmaker agreeing to start takeover talks. (Photograph: Brendan McDermid/Reuters)

Dublin based Horizon Pharma has raised its offer to buy Depomed to $33 per share, contingent on the smaller drugmaker agreeing to start takeover talk(...)

Pharmaceutical firm Horizon Pharma today announced 60 new jobs at the official opening of its global headquarters in Dublin.

Pharmaceutical firm Horizon Pharma today announced 60 new jobs at the official opening of its global headquarters in Dublin.The positions will be crea(...)

US medical device maker Medtronic’s plan to move its tax base to Ireland may be in doubt under rules announced by the Obama administration yesterday.

Medtronic, the Minnesota-based medical device maker that’s planning to take an Irish tax address, may become one of the biggest losers under rules ann(...)

M&A activity in Ireland is at its strongest since 2008 with 42 deals announced during the first half of the year, according to new figures compile(...)

Vidara  markets Actimmune, a drug that  is used to treat severe, malignant osteopetrosis.

Dublin-based pharmaceutical company Vidara Therapeutics has been acquired by US drug giant Horizon Pharma in a deal worth $660 million (€474 mi(...)